IP6K1 Inhibitors
IP6K1 inhibitors encompass a group of chemicals that can indirectly modulate the activity of IP6K1. These indirect modulators can affect the substrate availability, alter the enzyme's cofactors, or impact associated signaling cascades. For instance, since IP6K1 requires IP6 as a substrate to produce IP7, lithium's action of depleting inIt appears there was a mistake in the previous message. Let me complete the description of the chemical class called IP6K1 Inhibitors.
IP6K1 inhibitors, as a chemical class, are defined by their ability to influence the activity of inositol hexakisphosphate kinase 1 (IP6K1), an enzyme that phosphorylates inositol hexakisphosphate (IP6) to produce inositol pyrophosphate (IP7). The inhibitors listed do not bind directly to IP6K1 but act on pathways that either regulate IP6K1 or affect its substrate availability and cofactor interactions. For instance, lithium's action leads to a depletion of inositol levels by inhibiting inositol monophosphatase, which can reduce IP6 levels and consequently decrease IP7 production by IP6K1. Additionally, compounds such as N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine can impact ATP levels, which is a necessary cofactor for IP6K1's kinase activity. Further indirect inhibition can be achieved through the modulation of related signaling pathways. Inhibitors of PI3K, such as wortmannin and LY294002, affect the PI3K/AKT pathway, which can alter the turnover of inositol phosphates and phosphoinositides, indirectly influencing IP6K1. The kinase inhibitor staurosporine, although not selective, may impact kinases that are upstream or downstream of IP6K1, affecting its activity by altering the cellular signaling milieu
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium interferes with inositol monophosphatase and can lead to lower levels of inositol triphosphate (IP3) and subsequently inositol hexaphosphate (IP6), the substrate of IP6K1, which can result in reduced production of IP7 by IP6K1. | ||||||
3′,4′-Difluoroacetophenone | 369-33-5 | sc-232180 | 1 g | $21.00 | ||
This compound is a known inhibitor of adenosine kinases and has been seen to impact cellular energy balance. While not a direct inhibitor of IP6K1, it can alter ATP levels and availability, which may indirectly influence IP6K1 activity as ATP is required for the kinase reaction. | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
EGTA chelates calcium ions and can disrupt calcium-dependent signaling pathways. Since IP6K1 can be influenced by intracellular calcium levels, altering calcium dynamics can indirectly affect IP6K1 activity. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $156.00 $612.00 | 27 | |
Calmidazolium is a calmodulin antagonist; calmodulin is a calcium-binding messenger protein that can influence various signaling pathways. By inhibiting calmodulin, this compound can indirectly affect pathways that potentially overlap with IP6K1 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a potent kinase inhibitor with broad specificity, staurosporine can inadvertently affect various kinases and possibly downstream or upstream components of signaling pathways that involve IP6K1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of phosphoinositide 3-kinases (PI3K), which can indirectly affect IP6K1 activity by modulating the PI3K/AKT pathway and influencing the turnover of inositol phosphates and phosphoinositides. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in cell growth and proliferation. Since mTOR signaling can intersect with pathways involving IP6K1, rapamycin can indirectly affect IP6K1's role in the cell. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor that, like wortmannin, can reduce PI3K activity and therefore potentially affect the inositol phosphate turnover and indirectly the activity of IP6K1. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine is an autophagy inhibitor that can affect cellular recycling pathways, potentially altering the turnover of proteins and other molecules which may indirectly impact IP6K1 activity. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is a flavonoid that shows broad kinase inhibition properties. Through its effects on various cellular kinases, it can indirectly influence the activity of IP6K1 by altering signaling pathways that are either upstream or downstream of IP6K1. | ||||||